Krisztina Fischer, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Problem-Based Learning | 2 | 2023 | 361 | 0.690 |
Why?
|
| Education, Medical | 2 | 2023 | 1721 | 0.680 |
Why?
|
| Concept Formation | 1 | 2019 | 158 | 0.610 |
Why?
|
| Ultrasonic Therapy | 4 | 2015 | 235 | 0.600 |
Why?
|
| Education, Dental | 1 | 2019 | 215 | 0.550 |
Why?
|
| Ultrasonics | 3 | 2017 | 212 | 0.540 |
Why?
|
| Microvessels | 2 | 2016 | 544 | 0.420 |
Why?
|
| Curriculum | 1 | 2023 | 3605 | 0.360 |
Why?
|
| Microbubbles | 3 | 2017 | 128 | 0.350 |
Why?
|
| Reperfusion Injury | 1 | 2016 | 1026 | 0.340 |
Why?
|
| Kidney | 2 | 2016 | 7186 | 0.300 |
Why?
|
| High-Energy Shock Waves | 2 | 2015 | 36 | 0.250 |
Why?
|
| Fluorocarbons | 1 | 2009 | 452 | 0.240 |
Why?
|
| Ultrasonography | 2 | 2016 | 5985 | 0.230 |
Why?
|
| Acute Kidney Injury | 1 | 2016 | 1972 | 0.230 |
Why?
|
| Nephrotic Syndrome | 1 | 2007 | 389 | 0.230 |
Why?
|
| Glomerular Filtration Rate | 1 | 2009 | 2170 | 0.200 |
Why?
|
| Contrast Media | 2 | 2016 | 5300 | 0.190 |
Why?
|
| Tissue Scaffolds | 3 | 2014 | 956 | 0.180 |
Why?
|
| Group Processes | 1 | 2019 | 225 | 0.150 |
Why?
|
| Tissue Engineering | 3 | 2014 | 1880 | 0.150 |
Why?
|
| RNA | 1 | 2007 | 2749 | 0.150 |
Why?
|
| Liver Neoplasms | 1 | 2010 | 4253 | 0.120 |
Why?
|
| Learning | 1 | 2023 | 1713 | 0.110 |
Why?
|
| Abducens Nerve | 1 | 2012 | 28 | 0.110 |
Why?
|
| Blood-Brain Barrier | 2 | 2017 | 1017 | 0.110 |
Why?
|
| Echoencephalography | 1 | 2013 | 135 | 0.110 |
Why?
|
| Stereotaxic Techniques | 1 | 2014 | 536 | 0.100 |
Why?
|
| Cooperative Behavior | 1 | 2019 | 1504 | 0.100 |
Why?
|
| Sonication | 3 | 2017 | 83 | 0.090 |
Why?
|
| Evoked Potentials | 1 | 2015 | 1056 | 0.090 |
Why?
|
| Printing | 1 | 2009 | 46 | 0.090 |
Why?
|
| Motor Cortex | 2 | 2014 | 986 | 0.090 |
Why?
|
| Urination | 1 | 2009 | 204 | 0.080 |
Why?
|
| Cell Culture Techniques | 3 | 2014 | 1678 | 0.080 |
Why?
|
| Forearm | 2 | 2000 | 409 | 0.080 |
Why?
|
| Dextrans | 1 | 2009 | 595 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 1 | 2016 | 6386 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2017 | 8301 | 0.070 |
Why?
|
| Brain Waves | 1 | 2011 | 401 | 0.070 |
Why?
|
| Rabbits | 2 | 2011 | 4894 | 0.070 |
Why?
|
| Cognition | 1 | 2023 | 6770 | 0.070 |
Why?
|
| Blotting, Northern | 1 | 2007 | 1581 | 0.070 |
Why?
|
| Rats | 8 | 2017 | 24260 | 0.070 |
Why?
|
| Keratinocytes | 1 | 2008 | 798 | 0.060 |
Why?
|
| Animals | 13 | 2017 | 168757 | 0.060 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2013 | 2016 | 0.060 |
Why?
|
| Creatinine | 1 | 2009 | 1919 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 2886 | 0.060 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2010 | 828 | 0.060 |
Why?
|
| In Situ Hybridization | 1 | 2007 | 1950 | 0.060 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2007 | 849 | 0.050 |
Why?
|
| Fibroblasts | 2 | 2010 | 4161 | 0.050 |
Why?
|
| Heart | 1 | 2014 | 4467 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2009 | 6365 | 0.050 |
Why?
|
| Brain | 5 | 2017 | 26385 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2007 | 1676 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4751 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 2015 | 5708 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 8949 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 3920 | 0.040 |
Why?
|
| DNA Repair | 1 | 2007 | 2046 | 0.040 |
Why?
|
| Femoral Vein | 1 | 1998 | 159 | 0.040 |
Why?
|
| Ligaments, Articular | 1 | 2000 | 298 | 0.040 |
Why?
|
| Nerve Compression Syndromes | 1 | 1998 | 160 | 0.040 |
Why?
|
| Positron-Emission Tomography | 1 | 2013 | 6234 | 0.040 |
Why?
|
| Cell Survival | 3 | 2014 | 5882 | 0.040 |
Why?
|
| Collagen | 3 | 2010 | 2689 | 0.040 |
Why?
|
| Elbow Joint | 1 | 2000 | 357 | 0.030 |
Why?
|
| Humans | 9 | 2023 | 744343 | 0.030 |
Why?
|
| Stem Cells | 1 | 2009 | 3567 | 0.030 |
Why?
|
| Epilepsy | 1 | 2011 | 3310 | 0.030 |
Why?
|
| Skin | 1 | 2008 | 4364 | 0.030 |
Why?
|
| Sciatic Nerve | 1 | 1998 | 607 | 0.030 |
Why?
|
| Cell Enlargement | 1 | 2014 | 61 | 0.030 |
Why?
|
| Elastomers | 1 | 2014 | 71 | 0.030 |
Why?
|
| Male | 10 | 2017 | 350118 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2017 | 35421 | 0.030 |
Why?
|
| Hydrogels | 2 | 2009 | 724 | 0.030 |
Why?
|
| Mechanical Phenomena | 1 | 2014 | 140 | 0.030 |
Why?
|
| Capillary Permeability | 1 | 2017 | 798 | 0.030 |
Why?
|
| Sheep | 1 | 2015 | 1437 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2014 | 964 | 0.030 |
Why?
|
| Absorbable Implants | 1 | 2014 | 342 | 0.030 |
Why?
|
| Pentylenetetrazole | 1 | 2011 | 69 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 15076 | 0.020 |
Why?
|
| Materials Testing | 1 | 2014 | 867 | 0.020 |
Why?
|
| DNA Fragmentation | 1 | 2011 | 242 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2011 | 643 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 20129 | 0.020 |
Why?
|
| Neurons | 1 | 2009 | 9338 | 0.020 |
Why?
|
| Transducers | 1 | 2011 | 252 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2011 | 876 | 0.020 |
Why?
|
| Ulna | 2 | 2000 | 133 | 0.020 |
Why?
|
| Cell Aggregation | 1 | 2009 | 244 | 0.020 |
Why?
|
| Electrophysiological Phenomena | 1 | 2011 | 315 | 0.020 |
Why?
|
| Mice | 1 | 2016 | 81183 | 0.020 |
Why?
|
| Eye Movements | 1 | 2012 | 507 | 0.020 |
Why?
|
| Gelatin | 1 | 2010 | 225 | 0.020 |
Why?
|
| Biological Transport | 1 | 2013 | 2118 | 0.020 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2008 | 149 | 0.020 |
Why?
|
| Body Temperature | 1 | 2011 | 777 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2014 | 3144 | 0.020 |
Why?
|
| Spheroids, Cellular | 1 | 2009 | 351 | 0.020 |
Why?
|
| Polymers | 1 | 2014 | 1621 | 0.020 |
Why?
|
| Culture Media | 1 | 2009 | 908 | 0.020 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1989 | 906 | 0.020 |
Why?
|
| Artificial Organs | 1 | 2009 | 204 | 0.020 |
Why?
|
| Radius | 2 | 2000 | 422 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2009 | 813 | 0.020 |
Why?
|
| Somatosensory Cortex | 1 | 2011 | 528 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2017 | 2731 | 0.020 |
Why?
|
| Prognosis | 1 | 2007 | 29063 | 0.020 |
Why?
|
| Random Allocation | 1 | 2011 | 2429 | 0.020 |
Why?
|
| Particle Size | 1 | 2010 | 1642 | 0.020 |
Why?
|
| Perfusion | 1 | 2010 | 1360 | 0.020 |
Why?
|
| Models, Animal | 1 | 2012 | 2171 | 0.020 |
Why?
|
| Cross-Linking Reagents | 1 | 2008 | 694 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2007 | 23403 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 11366 | 0.010 |
Why?
|
| Visual Cortex | 1 | 2011 | 1149 | 0.010 |
Why?
|
| Time Factors | 2 | 2017 | 40075 | 0.010 |
Why?
|
| Myocardium | 1 | 2014 | 4776 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2009 | 1741 | 0.010 |
Why?
|
| Glucose | 1 | 2013 | 4397 | 0.010 |
Why?
|
| Pronation | 1 | 2000 | 51 | 0.010 |
Why?
|
| Biocompatible Materials | 1 | 2009 | 1736 | 0.010 |
Why?
|
| Supination | 1 | 2000 | 68 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1989 | 2540 | 0.010 |
Why?
|
| Ligaments | 1 | 1999 | 128 | 0.010 |
Why?
|
| Compressive Strength | 1 | 1999 | 169 | 0.010 |
Why?
|
| Wrist Joint | 1 | 2000 | 256 | 0.010 |
Why?
|
| Models, Biological | 2 | 2008 | 9583 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 2009 | 19229 | 0.010 |
Why?
|
| Cadaver | 1 | 2000 | 1337 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2011 | 6150 | 0.010 |
Why?
|
| Demyelinating Diseases | 1 | 1998 | 354 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2011 | 6669 | 0.010 |
Why?
|
| Nerve Fibers | 1 | 1998 | 687 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 1999 | 1686 | 0.010 |
Why?
|
| Nerve Degeneration | 1 | 1998 | 748 | 0.010 |
Why?
|
| Safety | 1 | 1998 | 1186 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2009 | 10481 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 1998 | 2124 | 0.010 |
Why?
|
| Cicatrix | 1 | 1998 | 764 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 18029 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 1989 | 10180 | 0.010 |
Why?
|
| Walking | 1 | 1998 | 1180 | 0.010 |
Why?
|
| Action Potentials | 1 | 1998 | 1806 | 0.010 |
Why?
|
| Antigens, CD7 | 1 | 1989 | 21 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 1998 | 5078 | 0.000 |
Why?
|
| Recurrence | 1 | 1998 | 8340 | 0.000 |
Why?
|
| Computer Simulation | 1 | 1999 | 6196 | 0.000 |
Why?
|
| Clone Cells | 1 | 1989 | 1692 | 0.000 |
Why?
|
| Antigens, Surface | 1 | 1989 | 1663 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1998 | 9146 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 1998 | 19905 | 0.000 |
Why?
|
| Flow Cytometry | 1 | 1989 | 5974 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1989 | 5524 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1998 | 39050 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1989 | 11483 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 1998 | 63114 | 0.000 |
Why?
|
| Aged | 1 | 2000 | 163280 | 0.000 |
Why?
|
| Middle Aged | 1 | 2000 | 213383 | 0.000 |
Why?
|
| Female | 1 | 2000 | 380194 | 0.000 |
Why?
|